ELV

Elevance Health
D

ELV

Arincen57/100B

Elevance Health income statement 1998–2026

201.83B USD over the last twelve months, and 199.13B USD in fiscal year 2025.

Revenue Operating income Net income

Click a line's chart icon in the table to add it to the chart; hover over it for a quick look.

Fiscal year
TTM
30 Sept 2026
FY2025
31 Dec 2025
FY2024
31 Dec 2024
FY2023
31 Dec 2023
FY2022
31 Dec 2022
FY2021
31 Dec 2021
FY2020
31 Dec 2020
FY2019
31 Dec 2019
FY2018
31 Dec 2018
FY2017
31 Dec 2017
FY2016
31 Dec 2016
Revenue
201.83B199.13B176.81B171.34B156.60B138.64B121.87B104.21B92.11B90.04B84.98B
Revenue growth
+3.60%+12.62%+3.19%+9.42%+12.95%+13.76%+16.94%+13.15%+2.29%+5.96%+7.24%
Cost of revenue
128.05B148.22B127.57B124.33B116.64B102.65B88.05B81.79B71.90B72.24B66.83B
Gross profit
73.78B50.90B49.24B47.01B39.95B35.99B33.82B22.43B20.21B17.80B18.14B
Gross margin
36.55%25.56%27.85%27.44%25.51%25.96%27.75%21.52%21.94%19.77%21.35%
Selling, general and administrative
—0.000.000.000.000.000.000.000.000.000.00
Operating expenses
66.32B42.79B40.36B38.27B31.50B27.05B26.11B15.69B14.37B12.82B12.72B
7.46B8.11B8.89B8.75B8.45B8.95B7.71B6.73B5.84B4.99B5.42B
Operating income growth
-12.03%-8.73%+1.64%+3.48%-5.53%+16.02%+14.53%+15.35%+17.09%-8.01%+1.14%
Operating margin
3.69%4.07%5.03%5.10%5.40%6.45%6.33%6.46%6.34%5.54%6.38%
Interest expense
1.14B1.40B1.19B1.03B851.00M798.00M784.00M746.00M753.00M739.00M723.00M
Other non-operating income
-1.21B-1.40B-984.00M-1.03B-851.00M-1.02B-1.47B-748.00M-769.00M-1.02B-863.70M
Pretax income
6.25B6.71B7.90B7.72B7.60B7.93B6.24B5.99B5.07B3.96B4.56B
Income tax
1.15B1.05B1.93B1.72B1.71B1.83B1.67B1.18B1.32B121.00M2.09B
Effective tax rate
18.35%15.63%24.46%22.35%22.53%23.09%26.71%19.68%26.01%3.05%45.78%
5.14B5.66B5.98B5.99B5.89B6.10B4.57B4.81B3.75B3.84B2.47B
Net income growth
-7.12%-5.32%-0.12%+1.58%-3.44%+33.51%-4.89%+28.19%-2.41%+55.59%-3.52%
Net margin
2.55%2.84%3.38%3.49%3.76%4.40%3.75%4.61%4.07%4.27%2.91%
Basic shares
219.43M221.80M232.87M233.07M240.00M243.80M250.80M255.50M254.30M256.08M263.75M
Diluted shares
219.43M221.80M232.90M237.40M242.80M246.80M254.30M260.30M254.30M267.80M268.10M
Change in diluted shares
-3.54%-4.77%-1.90%-2.22%-1.62%-2.95%-2.31%+2.36%-5.04%-0.11%-1.76%
EPS (basic)
23.4825.1825.8125.3824.5625.2518.2318.8114.5314.709.39
EPS (diluted)
23.4525.1225.6825.2224.2824.7317.9818.4714.1914.359.21
EPS growth
-4.13%-2.18%+1.82%+3.87%-1.82%+37.54%-2.65%+30.16%-1.12%+55.81%-1.81%
Dividends per share
6.876.846.525.925.124.523.803.203.002.702.60
Dividend growth
+1.63%+4.91%+10.14%+15.63%+13.27%+18.95%+18.75%+6.67%+11.11%+3.85%+4.00%
EBITDA
8.88B9.66B10.48B10.49B10.13B10.03B8.18B7.86B6.95B5.59B6.19B
EBITDA margin
4.40%4.85%5.93%6.12%6.47%7.23%6.71%7.55%7.55%6.21%7.28%
EBIT
7.39B8.11B9.09B8.75B8.45B8.72B7.02B6.73B5.82B4.70B5.28B

Figures in USD. Shares and EPS are adjusted for stock splits. Quarterly growth is on the same quarter a year before; TTM is the last four quarters.

Common questions about Elevance Health's income statement

Source: Financial Modeling Prep